Cytotoxicity-dependent APO-1 (Fas/CD95)-associated Proteins Form a Death-inducing Signaling Complex (DISC) with the Receptor

Overview

Journal EMBO J

Specialties Biotechnology
Molecular Biology

Date 1995 Nov 15

PMID 8521815

Citations 574

Authors

F C Kischkel

S Hellbardt

I Behrmann

M Germer

M Pawlita

P H Krammer

M E Peter

Affiliations

Soon will be listed here.

Abstract

APO-1 (Fas/CD95), a member of the tumor necrosis factor receptor superfamily, induces apoptosis upon receptor oligomerization. In a search to identify intracellular signaling molecules coupling to oligomerized APO-1, several cytotoxicity-dependent APO-1-associated proteins (CAP) were immunoprecipitated from the apoptosis-sensitive human leukemic T cell line HUT78 and the lymphoblastoid B cell line SKW6.4. CAP1-3 (27-29 kDa) and CAP4 (55 kDa), instantly detectable after the crosslinking of APO-1, were associated only with aggregated (the signaling form of APO-1) and not with monomeric APO-1. CAP1 and CAP2 were identified as serine phosphorylated MORT1/FADD. The association of CAP1-4 with APO-1 was not observed with C-terminally truncated non-signaling APO-1. In addition, CAP1 and CAP2 did not associate with an APO-1 cytoplasmic tail carrying the lprcg amino acid replacement. Moreover, no APO-1-CAP association was found in the APO-1+, anti-APO-1-resistant pre-B cell line Boe. Our data suggest that in vivo CAP1-4 are the APO-1 apoptosis-transducing molecules.

Citing Articles

Targeting caspase-8: a new strategy for combating hepatocellular carcinoma.

Chen H, Lin Y, Chen J, Luo X, Kan Y, He Y Front Immunol. 2024; 15:1501659.

PMID: 39726605 PMC: 11669555. DOI: 10.3389/fimmu.2024.1501659.

Targeting programmed cell death in diabetic kidney disease: from molecular mechanisms to pharmacotherapy.

Liu F, Yang Z, Li J, Wu T, Li X, Zhao L Mol Med. 2024; 30(1):265.

PMID: 39707216 PMC: 11660506. DOI: 10.1186/s10020-024-01020-5.

The Crosstalk of Apoptotic and Non-Apoptotic Signaling in CD95 System.

Seyrek K, Espe J, Reiss E, Lavrik I Cells. 2024; 13(21.

PMID: 39513921 PMC: 11545656. DOI: 10.3390/cells13211814.

Formation of a giant unilocular vacuole via macropinocytosis-like process confers anoikis resistance.

Kim J, Kim D, Kim D, Lee S, Jang W, Lim D Elife. 2024; 13.

PMID: 39508547 PMC: 11542918. DOI: 10.7554/eLife.96178.

Reverse hierarchical DED assembly in the cFLIP-procaspase-8 and cFLIP-procaspase-8-FADD complexes.

Yang C, Tseng Y, Tu Y, Kuo B, Hsu L, Lien C Nat Commun. 2024; 15(1):8974.

PMID: 39419969 PMC: 11487272. DOI: 10.1038/s41467-024-53306-1.

References

Yin T, Tsang M, Yang Y . JAK1 kinase forms complexes with interleukin-4 receptor and 4PS/insulin receptor substrate-1-like protein and is activated by interleukin-4 and interleukin-9 in T lymphocytes. J Biol Chem. 1994; 269(43):26614-7. View

Chan A, Desai D, Weiss A . The role of protein tyrosine kinases and protein tyrosine phosphatases in T cell antigen receptor signal transduction. Annu Rev Immunol. 1994; 12:555-92. DOI: 10.1146/annurev.iy.12.040194.003011. View

Los M, van de Craen M, Penning L, Schenk H, Westendorp M, Baeuerle P . Requirement of an ICE/CED-3 protease for Fas/APO-1-mediated apoptosis. Nature. 1995; 375(6526):81-3. DOI: 10.1038/375081a0. View

Pleiman C, Abrams C, Gauen L, Bedzyk W, Jongstra J, Shaw A . Distinct p53/56lyn and p59fyn domains associate with nonphosphorylated and phosphorylated Ig-alpha. Proc Natl Acad Sci U S A. 1994; 91(10):4268-72. PMC: 43766. DOI: 10.1073/pnas.91.10.4268. View

Boldin M, Mett I, Varfolomeev E, Chumakov I, Shemer-Avni Y, Camonis J . Self-association of the "death domains" of the p55 tumor necrosis factor (TNF) receptor and Fas/APO1 prompts signaling for TNF and Fas/APO1 effects. J Biol Chem. 1995; 270(1):387-91. DOI: 10.1074/jbc.270.1.387. View

Krammer P, Dhein J, Walczak H, Behrmann I, Mariani S, Matiba B . The role of APO-1-mediated apoptosis in the immune system. Immunol Rev. 1994; 142:175-91. DOI: 10.1111/j.1600-065x.1994.tb00889.x. View

Chinnaiyan A, ORourke K, Tewari M, Dixit V . FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell. 1995; 81(4):505-12. DOI: 10.1016/0092-8674(95)90071-3. View

Oehm A, Behrmann I, Falk W, Pawlita M, Maier G, Klas C . Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. Sequence identity with the Fas antigen. J Biol Chem. 1992; 267(15):10709-15. View

Schall T, Lewis M, Koller K, Lee A, Rice G, Wong G . Molecular cloning and expression of a receptor for human tumor necrosis factor. Cell. 1990; 61(2):361-70. DOI: 10.1016/0092-8674(90)90816-w. View

10.

Gulbins E, Bissonnette R, Mahboubi A, Martin S, NISHIOKA W, Brunner T . FAS-induced apoptosis is mediated via a ceramide-initiated RAS signaling pathway. Immunity. 1995; 2(4):341-51. DOI: 10.1016/1074-7613(95)90142-6. View

11.

Upton C, Delange A, McFadden G . Tumorigenic poxviruses: genomic organization and DNA sequence of the telomeric region of the Shope fibroma virus genome. Virology. 1987; 160(1):20-30. DOI: 10.1016/0042-6822(87)90039-0. View

12.

Itoh N, Nagata S . A novel protein domain required for apoptosis. Mutational analysis of human Fas antigen. J Biol Chem. 1993; 268(15):10932-7. View

13.

Benhamou M, Ryba N, Kihara H, Nishikata H, Siraganian R . Protein-tyrosine kinase p72syk in high affinity IgE receptor signaling. Identification as a component of pp72 and association with the receptor gamma chain after receptor aggregation. J Biol Chem. 1993; 268(31):23318-24. View

14.

Stamenkovic I, Clark E, Seed B . A B-lymphocyte activation molecule related to the nerve growth factor receptor and induced by cytokines in carcinomas. EMBO J. 1989; 8(5):1403-10. PMC: 400967. DOI: 10.1002/j.1460-2075.1989.tb03521.x. View

15.

Durkop H, Latza U, Hummel M, Eitelbach F, Seed B, STEIN H . Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease. Cell. 1992; 68(3):421-7. DOI: 10.1016/0092-8674(92)90180-k. View

16.

Boldin M, Varfolomeev E, Pancer Z, Mett I, Camonis J, Wallach D . A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain. J Biol Chem. 1995; 270(14):7795-8. DOI: 10.1074/jbc.270.14.7795. View

17.

Brannan C, Copeland N, Jenkins N, Nagata S . Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature. 1992; 356(6367):314-7. DOI: 10.1038/356314a0. View

18.

Kwon B, Weissman S . cDNA sequences of two inducible T-cell genes. Proc Natl Acad Sci U S A. 1989; 86(6):1963-7. PMC: 286825. DOI: 10.1073/pnas.86.6.1963. View

19.

Eischen C, Dick C, Leibson P . Tyrosine kinase activation provides an early and requisite signal for Fas-induced apoptosis. J Immunol. 1994; 153(5):1947-54. View

20.

Lahti J, Xiang J, Heath L, Campana D, Kidd V . PITSLRE protein kinase activity is associated with apoptosis. Mol Cell Biol. 1995; 15(1):1-11. PMC: 231901. DOI: 10.1128/MCB.15.1.1. View